alivecor.comHealthcare / Medical DevicesFounded: 2010Funding to Date: $277.15MM
AliveCor is a tech-enabled cardiovascular health business. AliveCor ECG sensors, KardiaMobile®, KardiaMobile® 6L, and KardiaMobile® Card, retrieve and deliver heart data to patients and their care teams and are FDA cleared to detect a group of common arythmias. AliveCor was founded in 2010 by David Albert MD, Bruce Satchwell, and Kim Barnett and is headquartered in Mountain View, CA.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
08/16/2022 | Series F | $150MM | $xx.xx | $943.68MM | GE Healthcare, NGK-NTK, Khosla Ventures, Bold Capital Partners, Qualcomm Ventures, WP Global Partners | |
Price per Share
$xx.xx
Shares Outstanding
10,192,501
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
GE Healthcare, NGK-NTK, Khosla Ventures, Bold Capital Partners, Qualcomm Ventures, WP Global Partners
|
||||||
11/16/2020 | Series E | $65MM | $xx.xx | $449.94MM | OMRON, Khosla Ventures, WP Global Partners, Qualcomm Ventures, Bold Capital Partners | |
Price per Share
$xx.xx
Shares Outstanding
6,688,757
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
OMRON, Khosla Ventures, WP Global Partners, Qualcomm Ventures, Bold Capital Partners
|
||||||
03/16/2017 | Series D | $30.08MM | $xx.xx | $173.09MM | OMRON, Mayo Clinic | |
Price per Share
$xx.xx
Shares Outstanding
6,147,014
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
OMRON, Mayo Clinic
|
||||||
03/31/2016 | Series C-2 | $5.74MM | $xx.xx | $88.15MM | WP Global Partners | |
Price per Share
$xx.xx
Shares Outstanding
1,862,235
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
WP Global Partners
|
||||||
03/31/2016 | Series C-1 | $5.14MM | $xx.xx | $88.15MM | WP Global Partners | |
Price per Share
$xx.xx
Shares Outstanding
2,477,081
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
WP Global Partners
|
||||||
03/31/2016 | Series C | $8.03MM | $xx.xx | $88.15MM | WP Global Partners | |
Price per Share
$xx.xx
Shares Outstanding
2,082,197
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
WP Global Partners
|
||||||
06/11/2012 | Series B-1 | $10.5MM | $xx.xx | $52.63MM | Khosla Ventures, Qualcomm Ventures, Oklahoma Life Sciences Fund, Bold Capital Partners | |
Price per Share
$xx.xx
Shares Outstanding
1,049,474
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Khosla Ventures, Qualcomm Ventures, Oklahoma Life Sciences Fund, Bold Capital Partners
|
||||||
08/23/2011 | Series A-1 | $2.64MM | $xx.xx | $13.22MM | Qualcomm Ventures, Oklahoma Life Sciences Fund, Burrill & Company | |
Price per Share
$xx.xx
Shares Outstanding
528,730
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Qualcomm Ventures, Oklahoma Life Sciences Fund, Burrill & Company
|